Risks and benefits of postmenopausal combined hormone replacement therapy

Medical Journal of Australia

Volumn 177, Issue 4, 2002, Pages 173-174

  Tattersall, Martin H N ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; ESTROGEN; PROGESTERONE; VITAMIN D;

AUSTRALIA; BREAST CANCER; CALCIUM INTAKE; CANCER RISK; CLINICAL OBSERVATION; CLINICAL TRIAL; COLORECTAL CANCER; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EDITORIAL; EVIDENCE BASED MEDICINE; FEMALE; FRACTURE; HEART DISEASE; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LONG TERM CARE; LUNG EMBOLISM; POSTMENOPAUSE; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; SHORT COURSE THERAPY; UTERUS CANCER; VITAMIN SUPPLEMENTATION;

EID: 0037135776     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2002.tb04724.x     Document Type: Editorial

References (5)

1. Hormone replacement therapy in women at risk of cardiovascular disease and osteoporosis in South Australia in 1997
2. Long-term hormone replacement therapy
3. Cardioprotective effect of hormone replacement therapy in postmenopausal women: Is the evidence biased?
4. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial
5. Failure of estrogen plus progestin therapy for prevention